Harbor Investment Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49K Hold
52
﹤0.01% 1218
2026
Q1
$1.64K Hold
52
﹤0.01% 1123
2025
Q4
$1.53K Buy
+52
New +$1.45K ﹤0.01% 1147
2024
Q3
Sell
-63
Closed -$1.87K 1278
2024
Q2
$1.87K Hold
63
﹤0.01% 1080
2024
Q1
$1.9K Hold
63
﹤0.01% 1127
2023
Q4
$1.8K Hold
63
﹤0.01% 1061
2023
Q3
$2.33K Sell
63
-1,861
-97% -$71.1K ﹤0.01% 1025
2023
Q2
$75.1K Sell
1,924
-185
-9% -$7.25K 0.01% 583
2023
Q1
$77K Hold
2,109
0.01% 573
2022
Q4
$65K Buy
+2,109
New +$65.5K 0.01% 613

Other funds holding RTO

Harbor Investment Advisory's RTO Position: Q2 2026 in Review

Harbor Investment Advisory held its Rentokil (RTO) position steady in Q2 2026 at 52 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Harbor Investment Advisory first reported a position in RTO in Q4 2022 and has held it in 10 quarters since. The position peaked at $77K in Q1 2023. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Harbor Investment Advisory held 52 shares of Rentokil worth $1.49K as of Q2 2026.
  • Harbor Investment Advisory left its Rentokil share count unchanged in Q2 2026.
  • Rentokil made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1218 holding.
  • Harbor Investment Advisory first reported a position in Rentokil in Q4 2022 and has held it in 10 quarters since.
  • Harbor Investment Advisory's Rentokil position peaked at $77K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.